32 /100
MEDIUM RISK
Score updated Jul 14, 2026

XOMAP — XOMA Royalty Corporation Dilution Risk Tracker

Track XOMAP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XOMAP — Get alerts when the score changes →

As of July 14, 2026, XOMA Royalty Corporation (XOMAP) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. XOMA Royalty Corporation has 12.54M shares outstanding, 85 institutional holders tracked. Key dilution vectors include 19.4K outstanding warrants, approximately 662 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
92
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for XOMAP.
🔔 Track XOMAP — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding12.54M
Float882.0K
Cash$85.60M
Debt$102.84M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 78.3% shares (2026Q1 vs prior)
85 institutional holders · 14.99M shares
#1 MORGAN STANLEY 5.06M shares
#2 BVF INC/IL 2.59M shares
#3 FMR LLC 1.30M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest276
Days to Cover1.0
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2011
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for XOMAP Shareholders

XOMA Royalty Corporation (XOMAP) has a DilutionScore of 32/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for XOMAP shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for XOMAP in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XOMAP alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track XOMAP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XOMAP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for XOMAP
📊 XOMAP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XOMAP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.